Does multi-vessel revascularisation reduce long-term MACE compared to target-vessel only angioplasty in patients with ST-elevation myocardial infarction?
In patients with STEMI, multivessel revascularization (whether staged or simultaneous) reduces long-term major adverse cardiac events compared to culprit-vessel only angioplasty.
Culprit vessel-only angioplasty was associated with the highest rate of long-term MACE compared with multivessel treatment. Patients scheduled for staged revascularisation experienced a similar rate of MACE to patients undergoing complete simultaneous treatment of non-IRA.
Politi et al. (Wed,) studied this question.